In the course of long-term monitoring, we have realized that the GI-19 lineage of IBV has shown a significant trend of evolution with potential pathogenic and antigenic changes, especially after 2018.
← all excerpts
Molecular surveillance of GI-19 lineage infectious bronchitis virus in China: divergent evolution and efficacy assessment of QXL87 vaccine against heterologous clades.
1
—
—